Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01931488 : 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.
PhasePhase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Age ? 18

- Signed Informed Consent

- Patients diagnosed with Parkinson disease

- Patients with histologically confirmed neuroendocrine tumors

Exclusion Criteria:

- Age < 18

- Any cardiovascular disease

- Taking medications that influence the sympathetic system
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557